AJP - GI Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol (November 20, 2008). doi:10.1152/ajpgi.90488.2008 Free Article
This Article
Free upon publication Free Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
296/2/G330    most recent
90488.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mani, A. R
Right arrow Articles by Morgan, M. Y
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mani, A. R
Right arrow Articles by Morgan, M. Y
Submitted on August 10, 2008
Revised on October 26, 2008
Accepted on November 18, 2008

Decreased heart rate variability in patients with cirrhosis relates to the presence and severity of hepatic encephalopathy

Ali R Mani1, Sara Montagnese1, Clive D Jackson2, Christopher W Jenkins1, Ian M Head1, Robert C Stephens1, Kevin P Moore1, and Marsha Y Morgan1*

1 University College London
2 Royal Free Hospital, NHS Trust

* To whom correspondence should be addressed. E-mail: mymorgan{at}medsch.ucl.ac.uk.

Background/Aims: Heart rate variability (HRV) is reduced in several clinical settings associated with either systemic inflammation or neuropsychiatric impairment. The possibility that the changes in HRV observed in patients with neuropsychiatric impairment might relate to the overproduction of inflammatory cytokines does not seem to have been considered in the studies undertaken to date. HRV is decreased in patients with liver cirrhosis but its relationship to the impairment of neuropsychiatric performance, commonly observed in these patients, is unknown. The aim of this study was to investigate the relationship between HRV, hepatic encephalopathy and production of inflammatory cytokines in patients with cirrhosis. Methods: Eighty patients with cirrhosis (53 men, 27 women; mean [±1SD] age 54±10 yr), classified as neuropsychiatrically unimpaired or as having minimal/overt hepatic encephalopathy, and 11 healthy subjects were studied. HRV was assessed by applying Poincaré plot analysis to the R-R interval series on a five minute ECG. Inflammatory cytokines (TNF-alpha, IL-6, IL-10, and IL-12) were measured in a subgroup of patients. Results: Long-term R-R variability was significantly decreased in the patients with cirrhosis, in parallel with the degree of neuropsychiatric impairment (p<0.01) and independently of the degree of hepatic dysfunction (p=0.011). The relative risk of death increased by 7.7% for every ms drop in this variable. Plasma levels of IL-6 significantly correlated with indices of both HRV and neuropsychiatric performance. Conclusions: The changes observed in HRV and in neuropsychiatric status in patients with cirrhosis are significantly correlated, possibly reflecting a common pathogenic mechanism mediated by inflammatory cytokines.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.